336 related articles for article (PubMed ID: 26614866)
1. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly.
Klepin HD
Clin Geriatr Med; 2016 Feb; 32(1):155-73. PubMed ID: 26614866
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia and myelodysplastic syndromes in older adults.
Klepin HD; Rao AV; Pardee TS
J Clin Oncol; 2014 Aug; 32(24):2541-52. PubMed ID: 25071138
[TBL] [Abstract][Full Text] [Related]
3. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia and myelodysplastic syndromes in older patients.
Estey E
J Clin Oncol; 2007 May; 25(14):1908-15. PubMed ID: 17488990
[TBL] [Abstract][Full Text] [Related]
5. Personalized treatment strategies for elderly patients with myelodysplastic syndromes.
Castelli R; Bergamaschini L; Schiavon R; Lambertenghi-Deliliers G
Expert Rev Hematol; 2017 Dec; 10(12):1077-1086. PubMed ID: 29069953
[TBL] [Abstract][Full Text] [Related]
6. Management of older adults with myelodysplastic syndromes (MDS).
Luskin MR; Abel GA
J Geriatr Oncol; 2018 Jul; 9(4):302-307. PubMed ID: 29290596
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
de Lima M; Giralt S
Semin Hematol; 2006 Apr; 43(2):107-17. PubMed ID: 16616044
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis.
Stauder R; Lambert J; Desruol-Allardin S; Savre I; Gaugler L; Stojkov I; Siebert U; Chevrou-Séverac H
Eur J Haematol; 2020 May; 104(5):476-487. PubMed ID: 31985078
[TBL] [Abstract][Full Text] [Related]
9. Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches.
Deschler B; de Witte T; Mertelsmann R; Lübbert M
Haematologica; 2006 Nov; 91(11):1513-22. PubMed ID: 17082009
[TBL] [Abstract][Full Text] [Related]
10. [Recent advances of studies on the therapy-related myelodysplastic syndromes/acute myeloid leukemia].
Li CJ; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1757-60. PubMed ID: 25543511
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.
Klimek VM
Curr Opin Hematol; 2013 Mar; 20(2):137-43. PubMed ID: 23343830
[TBL] [Abstract][Full Text] [Related]
12. Using Social Media to Uncover Treatment Experiences and Decisions in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis.
Booth A; Bell T; Halhol S; Pan S; Welch V; Merinopoulou E; Lambrelli D; Cox A
J Med Internet Res; 2019 Nov; 21(11):e14285. PubMed ID: 31755871
[TBL] [Abstract][Full Text] [Related]
13. Familial myelodysplastic syndrome/acute myeloid leukemia.
Churpek JE
Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
[TBL] [Abstract][Full Text] [Related]
14. Elderly acute myeloid leukemia: assessing risk.
Klepin HD
Curr Hematol Malig Rep; 2015 Jun; 10(2):118-25. PubMed ID: 25939828
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes in the United States: an update for clinicians.
Troy JD; Atallah E; Geyer JT; Saber W
Ann Med; 2014 Aug; 46(5):283-9. PubMed ID: 24716735
[TBL] [Abstract][Full Text] [Related]
16. Ultra-low-dose decitabine combined with autologous cytokine-induced killer cells for elderly patients with acute myeloid leukemia transformed from myelodysplastic syndrome.
Wang H; Yang B; Chi X; Cai L; Yu R; Zhu H; Tuo S; Zhang F; Wang X; Yang Y; Wu X; Li S; Lu X
Clin Ther; 2014 Jul; 36(7):1104-11. PubMed ID: 24986484
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
Carney DA; Westerman DA; Tam CS; Milner A; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Ritchie D; Came N; Seymour JF
Leukemia; 2010 Dec; 24(12):2056-62. PubMed ID: 20962860
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
19. Successful management of acute myeloid leukemia transformed from myelodysplastic syndromes in an elderly patient aged over 80 years old by ultralow dose decitabine combined with amifostine and autologous CIK cells.
Yang B; Wang HT; Cai LL; Zhao Y; Chi XH; Zhu HL; Ran HH; Yang Y; Yu RL; Li SW; Lu XC
Ann Hematol; 2014 Jul; 93(7):1233-5. PubMed ID: 24240975
[No Abstract] [Full Text] [Related]
20. DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome.
El Ghannam D; Taalab MM; Ghazy HF; Eneen AF
Blood Cells Mol Dis; 2014; 53(1-2):61-6. PubMed ID: 24512939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
